Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Change in Accured Expenses (2019 - 2025)

Volitionrx (VNRX) has disclosed Change in Accured Expenses for 9 consecutive years, with $993076.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses rose 3220.72% year-over-year to $993076.0, compared with a TTM value of $3568.0 through Sep 2025, down 99.55%, and an annual FY2024 reading of -$1.2 million, down 199.37% over the prior year.
  • Change in Accured Expenses was $993076.0 for Q3 2025 at Volitionrx, up from -$560926.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $1.2 million in Q4 2023 and bottomed at -$949636.0 in Q3 2023.
  • Average Change in Accured Expenses over 5 years is $99092.3, with a median of $3345.0 recorded in 2022.
  • The sharpest move saw Change in Accured Expenses tumbled 643.52% in 2021, then soared 36151.57% in 2023.
  • Year by year, Change in Accured Expenses stood at $549403.0 in 2021, then crashed by 99.39% to $3345.0 in 2022, then skyrocketed by 36151.57% to $1.2 million in 2023, then tumbled by 166.02% to -$800624.0 in 2024, then surged by 224.04% to $993076.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for VNRX at $993076.0 in Q3 2025, -$560926.0 in Q2 2025, and $372042.0 in Q1 2025.